Skip to content
Image: U.S. National Archives and Records Administration/Creative Commons Throughout her life, Rosalynn Carter was a true champion of public health. During her time as […]
Vaccinate Your Family remembers Rosalynn Carter Read More »
Clinical trial diversity has been one of the most pressing needs in the healthcare industry for decades. For this and many other reasons, the
BIO unveils updated resources to improve clinical trial diversity Read More »
Pharmacy benefit managers, or PBMs, have been in the political hot seat for a couple of years now—and for good reason. “Every day PBMs
As PBM reform maintains steam, biotech companies and patients are urged to take action Read More »
“We have 87 million patients in America who rely on Medicaid for either supplemental or primary coverage,” began Virginia McMillin of Jazz Pharmaceuticals during
How to protect patient access to Medicaid Read More »
“The Inflation Reduction Act (IRA) was one of President Biden’s signature achievements and will help many Americans,” began Christina Hochul of Alexion Pharmaceuticals, Inc.,
Inflation Reduction Act: Unintended consequences for rare disease, orphan drugs Read More »
The 2023 Biotechnology Innovation Organization (BIO) Investor Forum ended the way it began: with caution about the months ahead and hope companies will continue
The market outlook for life science – and how biotechs can weather the storm Read More »
Artificial Intelligence (AI) is saturating every aspect of human life—including life sciences. While the potential of AI and computational biology are vast, one of
How AI and computational biology can help us reach ‘undruggable’ targets Read More »
The wonder of RNA-based technology was long in its coming. But it has paid off throughout the COVID and post-COVID years. Plus, the breadth
RNA presents challenges, enormous opportunities, say biotech leaders Read More »
The only constant is change. The trick for entrepreneurs and investors, it would seem, is to map and anticipate that change and operate with
What investors look for in early-stage companies Read More »
Women’s health has long been an underserved area when it comes to clinical innovation, R&D, and funding—the Women’s Health Innovation Opportunity Map (WHOM) is
Women’s Health Innovation Opportunity Map launches Read More »
